We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$1.22B
AUM Growth
+$65.5M
Cap. Flow
+$34.8M
Cap. Flow %
2.85%
Top 10 Hldgs %
19.13%
Holding
431
New
24
Increased
129
Reduced
227
Closed
12

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$4.73M
2
VWR
VWR Corporation
VWR
+$3.87M
3
DD icon
DuPont de Nemours
DD
+$3.26M
4
CSCO icon
Cisco
CSCO
+$2.25M
5
HPE icon
Hewlett Packard
HPE
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 17.5%
2 Financials 16.63%
3 Healthcare 13.58%
4 Industrials 9.3%
5 Consumer Discretionary 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMJ
1
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$37.7M 3.09%
+1,370,871
New +$37.2M
AAPL icon
2
Apple
AAPL
$4.79T
$36.7M 3%
866,700
+36,448
+4% +$1.52M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.06T
$24.7M 2.02%
126,721
-4,640
-4% -$881K
INTC icon
4
Intel
INTC
$516B
$24.2M 1.98%
523,352
-5,323
-1% -$232K
JNJ icon
5
Johnson & Johnson
JNJ
$615B
$23M 1.89%
164,943
-3,418
-2% -$476K
CMCSA icon
6
Comcast
CMCSA
$84B
$21.6M 1.77%
540,041
-24,936
-4% -$937K
ED icon
7
Consolidated Edison
ED
$41.3B
$17.1M 1.4%
201,845
-4,492
-2% -$386K
NOC icon
8
Northrop Grumman
NOC
$74.6B
$16.5M 1.35%
53,684
-2,544
-5% -$764K
ELV icon
9
Elevance Health
ELV
$84.4B
$16.1M 1.32%
71,733
-613
-0.8% -$131K
MSFT icon
10
Microsoft
MSFT
$2.9T
$16M 1.31%
186,588
-4,862
-3% -$399K
AET
11
DELISTED
Aetna Inc
AET
$15.7M 1.28%
86,901
-8,444
-9% -$1.45M
UNH icon
12
UnitedHealth
UNH
$392B
$15.3M 1.26%
69,507
-3,988
-5% -$845K
IEMG icon
13
iShares Core MSCI Emerging Markets ETF
IEMG
$153B
$15.1M 1.23%
264,496
-1,379
-0.5% -$77K
PFE icon
14
Pfizer
PFE
$141B
$15M 1.23%
436,771
-4,929
-1% -$168K
BAC icon
15
Bank of America
BAC
$432B
$15M 1.23%
507,537
-26,443
-5% -$729K
C icon
16
Citigroup
C
$222B
$13.9M 1.14%
186,227
-1,678
-0.9% -$124K
AMGN icon
17
Amgen
AMGN
$198B
$13.4M 1.1%
76,997
+3,620
+5% +$641K
ALL icon
18
Allstate
ALL
$64.8B
$13.2M 1.08%
126,437
+1,176
+0.9% +$116K
IWC icon
19
iShares Micro-Cap ETF
IWC
$1.45B
$13.1M 1.07%
136,484
-2,412
-2% -$229K
EXC icon
20
Exelon
EXC
$47.8B
$12.9M 1.06%
460,075
+102,196
+29% +$2.94M
CSCO icon
21
Cisco
CSCO
$442B
$12.3M 1.01%
320,783
-62,995
-16% -$2.25M
DIS icon
22
Walt Disney
DIS
$166B
$12.3M 1%
114,030
-298
-0.3% -$30.7K
FNDX icon
23
Schwab Fundamental US Large Company Index ETF
FNDX
$26.5B
$12M 0.99%
964,524
+24,792
+3% +$299K
DD icon
24
DuPont de Nemours
DD
$18.9B
$12M 0.99%
66,755
-18,078
-21% -$3.26M
TRV icon
25
Travelers Companies
TRV
$82.1B
$11.8M 0.97%
86,885
-1,551
-2% -$205K

Similar funds

RegentAtlantic Capital's Q4 2017 Portfolio in Review

As of Q4 2017, RegentAtlantic Capital held 431 positions worth $1.22B, up 5.7% from $1.16B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

RegentAtlantic Capital's Q4 2017 filing shows 24 new, 129 increased, 227 reduced and 12 closed positions. Its largest new stake was JP Morgan Alerian MLP Index ETN 5/24/24: 1,370,871 shares worth $37.7M. The largest sale was PG&E, an estimated $4.73M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RegentAtlantic Capital's largest Q4 2017 buy was JP Morgan Alerian MLP Index ETN 5/24/24: 1,370,871 shares worth $37.7M.
  • RegentAtlantic Capital added most to Molson Coors Class B in Q4 2017, an estimated $7.27M increase.
  • RegentAtlantic Capital's biggest Q4 2017 reduction was PG&E, cutting an estimated $4.73M.
  • RegentAtlantic Capital fully exited VWR Corporation in Q4 2017, selling an estimated $3.87M.
  • RegentAtlantic Capital's ten largest holdings make up 19% of its $1.22B portfolio in Q4 2017.
  • RegentAtlantic Capital opened 24 new positions and closed 12 in Q4 2017.
  • RegentAtlantic Capital's portfolio value rose 5.7% quarter-over-quarter to $1.22B.

Based on RegentAtlantic Capital's 13F filing for Q4 2017, filed 23 Jan 2018.